Showing results (61-70 of 620) with videos related to
Sort By:
Pageof 62
Critical Reviews in Oncogenesis|January 1, 1991
Modulation of EGF receptor protooncogene expression by growth factors and hormones in human breast carcinoma cellsJ A Fernandez-PolCritical Reviews in Oncogenesis|January 1, 1992
Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cellsE Eigenbrodt, M Reinacher, U Scheefers-Borchel, et al.Critical Reviews in Oncogenesis|February 9, 2010
Inflammation versus adaptive immunity in cancer pathogenesisSheraz Yaqub, Einar Martin AandahlCritical Reviews in Oncogenesis|February 9, 2010
Structural and expression changes of septins in myeloid neoplasiaNuno Cerveira, Joana Santos, Manuel R TeixeiraCritical Reviews in Oncogenesis|April 2, 2018
Tumor-Suppressing Properties of Crocus sativus L.: Nature as an Anti-Cancer AgentEleni Kakouri, Kyriaki Hatziagapiou, Kostas Bethanis, et al.Critical Reviews in Oncogenesis|April 2, 2018
Genomic Pathology and Biomarkers in Breast CancerZhang Zhang, Ping TangCritical Reviews in Oncogenesis|April 2, 2018
The Roles of Chromatin Remodeling Genes in Pancreatic-Biliary MalignanciesClaudio Luchini, Alessia NottegarCritical Reviews in Oncogenesis|April 2, 2018
Xp11 Translocation Renal Cell Carcinoma and the Mesenchymal Counterparts: An Evolving Concept with Novel Insights on Clinicopathologic Features, Prognosis, Treatment, and ClassificationXiao-Tong Wang, Qiu-Yuan Xia, Xiao-Jun Zhou, et al.Critical Reviews in Oncogenesis|April 2, 2018
Therapeutic YY1 Inhibitors in Cancer: ALL in ONEBenjamin BonavidaCritical Reviews in Oncogenesis|April 2, 2018
The Forgotten YY2 in Reported YY1 Expression Levels in Human CancersSamantha Kaufhold, Nabil Aziz, Benjamin BonavidaPageof 62